Multicentre, randomised clinical trial comparing intravitreal aflibercept monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) for the treatment of polypoidal choroidal vasculopathy

PURPOSE: To compare the efficacy and safety of intravitreal aflibercept (IVA) monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) (IVA+RF-PDT) for the treatment of polypoidal choroidal vasculopathy (PCV). METHODS AND ANALYSIS: Multicentred, double-masked, rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Vyas, Chinmayi Himanshuroy, Cheung, Chui Ming Gemmy, Tan, Colin, Chee, Caroline, Wong, Kelly, Jordan-Yu, Janice Marie N., Wong, Tien Yin, Tan, Anna, Fenner, Beau, Sim, Shaun, Teo, Kelvin Yi Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286776/
https://www.ncbi.nlm.nih.gov/pubmed/34266844
http://dx.doi.org/10.1136/bmjopen-2021-050252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286776/
https://www.ncbi.nlm.nih.gov/pubmed/34266844
http://dx.doi.org/10.1136/bmjopen-2021-050252

Ejemplares similares